Skip to content

Evaluation of Drainage Methods After Endoscopic Submucosal Dissection Including the Papilla (ESDIP) for Papillary-Involving Duodenal Tumors

Evaluation of Drainage Methods After Endoscopic Submucosal Dissection Including the Papilla (ESDIP) for Papillary-Involving Duodenal Tumors - Evaluation of Drainage Methods After Endoscopic Submucosal Dissection Including the Papilla (ESDIP) for Papillary-Involving Duodenal Tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060004
Enrollment
20
Registered
2025-12-09
Start date
2025-12-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deuodenal tumor

Interventions

None listed

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients undergoing biliary and pancreatic duct cannulation for drainage after ESDIP for duodenal adenoma 2.Patients aged >19 and <100 years at the time of consent 3.Patients who provide written informed consent to participate in this study

Exclusion criteria

Exclusion criteria: 1.Patients with invasive cancer who are eligible for surgical treatment 2.Cases in which the attending physician judges participation in this study to be inappropriate 3.Patients who withdraw their consent and refuse participation after enrollment

Design outcomes

Primary

MeasureTime frame
Procedure time to achieve successful cannulation

Secondary

MeasureTime frame
Bleeding, Perforation, Pancreatitis, Total procedure time. Rate of hemoglobin decrease>2 g/dL, Blood transfusion

Countries

Japan

Contacts

Public ContactShintaro Kawasaki

Keio University School of Medicine Center for Diagnostic and Therapeutic Endoscopy

s.kawasaki@keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026